8月4日，Hinge Health盘中上涨5.14%，报78.55美元/股，成交额6295.57万美元。公司将于当日盘后发布Q2财报，市场情绪提前升温。
消息面上，市场一致预期本季度营收约2.01亿美元，同比增长60.38%，调整后每股收益预计为0.59美元，同比大增582.69%。此前公司已将Q2营收指引上调至2.00亿至2.02亿美元，全年营收展望提升至8.18亿至8.24亿美元，均高于华尔街预期。此外，Morgan Stanley于7月将目标价由72美元大幅上调至108美元并维持增持评级，RBC亦强调公司新产品与利润率改善带来的长期增长前景。近期一项研究显示其跌倒预防项目可使65岁以上人群跌倒次数减少37%，进一步验证临床价值。
Hinge Health是一家AI驱动的数字肌肉骨骼护理平台，通过可穿戴设备和专业临床团队提供从急性损伤到术后康复的全流程服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.